Bristol-Myers Squibb Company (BMY) stock: Winston Score and insider trades
Bristol-Myers Squibb Company (BMY) · USD. Read the company overview.
Winston Score: 66 out of 100, Good
A decent business — some strong pillars, some weaker.
- Quality: Exceptional (26/30)
- Growth: Good (12/20)
- Cash Flow: Exceptional (9/10)
- Stability: Strong (8/10)
- Valuation: Strong (7/10)
- Ownership: Weak (1/15)
Key Facts
Price: $62.93
Market Cap: $128.6B
Sector: Healthcare
Industry: Drug Manufacturers - General
Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-11-15.


